Crossmark

Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder

Crossref DOI link: https://doi.org/10.1186/s13722-025-00554-1

Published Online: 2025-03-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Heshmatipour, Matthew P.

Duvernay, Tyler M.

Hite, Desislava Z.

Versi, Eboo

Hite, Michael P.

Reeser, David F.

Prikhodko, Victor

Nelson, Ariana M.

Julian, Bina

Greenberg, Milton L.
Funding

Funding for this research was provided by:

The National Institute on Drug Abuse (3R43DA053055-01S1, 2R44DA051257-02, 3R43DA053055-01S1, 2R44DA051257-02, 3R43DA050399-01A1S1, 3R43DA053055-01S1, 3R43DA053010-01S1)
License Information

Text and Data Mining valid from 2025-03-12

Version of Record valid from 2025-03-12
More Information

Article History

Received: 21 September 2024

Accepted: 27 February 2025

First Online: 12 March 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below